Stockscreener 앱 받기
8.99
3.45%
0.30
시간 외 거래:
8.99
전일 마감가:
$8.69
열려 있는:
$8.69
하루 거래량:
879.79K
Relative Volume:
1.47
시가총액:
$365.06M
수익:
$324.01M
순이익/손실:
$-192.37M
주가수익비율:
-1.8808
EPS:
-4.78
순현금흐름:
$-23.46M
1주 성능:
-6.65%
1개월 성능:
-10.28%
6개월 성능:
-24.71%
1년 성능:
+25.21%
1일 변동 폭
$8.635
$9.10
1주일 범위
$8.38
$10.80
52주 변동 폭
$5.83
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
명칭
Angiodynamic Inc
전화
(518) 798-1215
주소
14 PLAZA DRIVE, LATHAM
ANGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
8.99 | 391.05M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-16 | 개시 | Lake Street | Buy |
| 2024-04-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-09-25 | 개시 | H.C. Wainwright | Buy |
| 2023-04-17 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | 개시 | Oppenheimer | Perform |
| 2020-11-25 | 업그레이드 | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2017-04-07 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-03-30 | 다운그레이드 | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | 개시 | Barclays | Equal Weight |
| 2016-11-04 | 개시 | Cantor Fitzgerald | Buy |
| 2016-04-08 | 재개 | Piper Jaffray | Neutral |
| 2016-01-08 | 재확인 | Canaccord Genuity | Buy |
| 2015-11-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | 재확인 | Canaccord Genuity | Hold |
| 2012-06-25 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | 업그레이드 | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2010-09-08 | 재확인 | Wedbush | Neutral |
모두보기
Angiodynamic Inc 주식(ANGO)의 최신 뉴스
What analysts say about AngioDynamics Inc. stockSignificant capital appreciation - Autocar Professional
What drives AngioDynamics Inc. stock priceExceptional risk-adjusted gains - Autocar Professional
Principal Financial Group Inc. Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Is AngioDynamics Inc. a good long term investmentHigh-velocity gains - jammulinksnews.com
AngioDynamics Inc. Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
HC Wainwright Reiterates Buy Rating for AngioDynamics (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) EBITDA Improves - FXDailyReport.Com
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance
AngioDynamics Reports Strong Growth in Fiscal 2025 - TipRanks
AngioDynamics Reports Strong Growth Amid Challenges - TipRanks
How AngioDynamics Inc. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
Why AngioDynamics Inc. stock attracts strong analyst attentionFree Stock Market Group - Newser
AngioDynamics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Inc reports results for the quarter ended May 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q4 2025 Earnings Call, Jul 15, 2025 - MarketScreener
What makes AngioDynamics Inc. stock price move sharplyProfitable Yet Secure Picks - Newser
AngioDynamics Delivers Strong Q4 As Med Tech Sales Jump - Finimize
AngioDynamics, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 - MarketScreener
AngioDynamics: Fiscal Q4 Earnings Snapshot - The Washington Post
Medical device maker AngioDynamics beats Q4 revenue estimates - MarketScreener
AngioDynamics Delivers Breakthrough Quarter: 22% MedTech Growth Drives Financial Turnaround - Stock Titan
What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings - Yahoo Finance
OneDigital Investment Advisors LLC Trims Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (ANGO) to Release Quarterly Earnings on Tuesday - Defense World
Medical Tech Leader AngioDynamics Sets Q4 Earnings Date: Key Financial Results Coming July 15 - Stock Titan
AngioDynamics, Inc.(NasdaqGS: ANGO) added to Russell 2000 Growth Index - MarketScreener
Global Clinical Trial Launches: New Device Targets 435,000 Annual Pulmonary Embolism Cases - Stock Titan
Ratio Examination: Angiodynamic Inc (ANGO)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Assenagon Asset Management S.A. - Defense World
Reviewing Intelligent Bio Solutions (NASDAQ:INBS) & AngioDynamics (NASDAQ:ANGO) - Defense World
Bank of America Corp DE Has $623,000 Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Jane Street Group LLC Has $117,000 Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
42,258 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Purchased by Squarepoint Ops LLC - Defense World
ProShare Advisors LLC Purchases Shares of 10,899 AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Deutsche Bank AG Acquires 16,905 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Are Medical Stocks Lagging AngioDynamics (ANGO) This Year? - Yahoo Finance
Ameriprise Financial Inc. Increases Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics Inc (ANGO) Shares Up 5.3% on May 28 - GuruFocus
AngioDynamics Secures $25M Credit Facility with JPMorgan - TipRanks
Nuveen Asset Management LLC Grows Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Angiodynamic Inc (ANGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.28%
자본화:
|
볼륨(24시간):